Table of Contents
Epidemiology Research International
Volume 2012 (2012), Article ID 136793, 13 pages
http://dx.doi.org/10.1155/2012/136793
Review Article

Globalization of Chagas Disease: A Growing Concern in Nonendemic Countries

1Department of Internal Medicine, Center for Global Health, University of New Mexico Health Science Center, MSC10 5550, Albuquerque, NM 87131, USA
2New Mexico VA Health Care System, 1501 San Pedro Blvd SE, Albuquerque, NM 87108, USA

Received 18 July 2012; Accepted 30 August 2012

Academic Editor: Alfonso J. Rodriguez-Morales

Copyright © 2012 Nicole Klein et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Dias, C. Bastos, E. Araújo et al., “Acute Chagas disease outbreak associated with oral transmission,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 41, no. 3, pp. 296–300, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. Centers for Disease Control and Prevention (CDC), “Blood donor screening for Chagas disease—United States, 2006-2007,” Morbidity and Mortality Weekly Report, vol. 56, no. 7, pp. 141–143, 2007. View at Google Scholar
  3. D. A. Leiby, B. A. Lenes, M. A. Tibeals, and M. T. Tames-Olmedo, “Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion,” New England Journal of Medicine, vol. 341, no. 16, pp. 1237–1239, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. L. V. Kirchhoff, “American trypanosomiasis (Chagas disease),” in Tropical Infectious Diseases: Principles, Pathogens & Practice, R. Guerrant, D. H. Walker, and P. F. Weller, Eds., p. 1082, Churchill Livingstone, Philadelphia, Pa, USA, 2nd edition, 2006. View at Google Scholar
  5. J. H. Maguire, R. Hoff, and I. Sherlock, “Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community,” Circulation, vol. 75, no. 6, pp. 1140–1145, 1987. View at Google Scholar · View at Scopus
  6. J. C. Pinto Dias, “Natural history of Chagas disease,” Arquivos Brasileiros de Cardiologia, vol. 65, no. 4, pp. 359–366, 1995. View at Google Scholar
  7. J. R. Coura and P. A. Vĩas, “Chagas disease: a new worldwide challenge,” Nature, vol. 465, no. 7301, pp. S6–S7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. C. P. Dias, A. Prata, and D. Correia, “Problems and perspectives for Chagas disease control: in search of a realistic analysis,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 41, no. 2, pp. 193–196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. Secretariat of World Health Organization, Chagas Disease: Control and Elimination, Secretariat of World Health Organization, 2009.
  10. F. Guhl, N. Pinto, and G. Aguilera, “Sylvatic triatominae: a new challenge in vector control transmission,” Memorias do Instituto Oswaldo Cruz, vol. 104, supplement 1, pp. 71–75, 2009. View at Google Scholar · View at Scopus
  11. D. T. John and K. L. Hoppe, “Trypanosoma cruzi from wild raccoons in Oklahoma,” American Journal of Veterinary Research, vol. 47, no. 5, pp. 1056–1059, 1986. View at Google Scholar · View at Scopus
  12. The Mariners Museum, http://ageofex.marinersmuseum.org/?type=webpage&id=48.
  13. J. P. Byrne, Encyclopedia of Pestilence, Pandemics, and Plagues, Greenwood Publishing Group, Westport, Conn, USA, 2008.
  14. L. Altman, Plague and Pestilence: A History of Infectious Disease, Enslows Publishers, Berkeley Heights, NJ, USA, 1998.
  15. E. L. Brown, D. M. Roellig, M. E. Gompper et al., “Seroprevalence of Trypanosoma cruzi among eleven potential reservoir species from six states across the southern United States,” Vector Borne and Zoonotic Diseases, vol. 10, no. 8, pp. 757–763, 2010. View at Google Scholar · View at Scopus
  16. C. E. Reisenman, G. Lawrence, P. G. Guerenstein, T. Gregory, E. Dotson, and J. G. Hildebrand, “Infection of kissing bugs with Trypanosoma cruzi, Tucson, Arizona, USA,” Emerging Infectious Diseases, vol. 16, no. 3, pp. 400–405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. A. Kjos, K. F. Snowden, and J. K. Olson, “Biogeography and Trypanosoma cruzi infection prevalence of chagas disease vectors in Texas, USA,” Vector-Borne and Zoonotic Diseases, vol. 9, no. 1, pp. 41–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. T. R. Navin, R. R. Roberto, and D. D. Juranek, “Human and sylvatic Trypanosoma cruzi infection in California,” American Journal of Public Health, vol. 75, no. 4, pp. 366–369, 1985. View at Google Scholar · View at Scopus
  19. D. E. Ochs, V. S. Hnilica, D. R. Moser, J. H. Smith, and L. V. Kirchhoff, “Postmortem diagnosis of autochthonous acute chagasic myocarditis by polymerase chain reaction amplification of a species-specific DNA sequence of Trypanosoma cruzi,” American Journal of Tropical Medicine and Hygiene, vol. 54, no. 5, pp. 526–529, 1996. View at Google Scholar · View at Scopus
  20. B. L. Herwaldt, M. J. Grijalva, A. L. Newsome et al., “Use of polymerase chain reaction to diagnose the fifth reported US case of autochthonous transmission of Trypanosoma cruzi, in Tennessee, 1998,” Journal of Infectious Diseases, vol. 181, no. 1, pp. 395–399, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. P. L. Dorn, L. Perniciaro, M. J. Yabsley et al., “Autochthonous transmission of Trypanosoma cruzi, Louisiana,” Emerging Infectious Diseases, vol. 13, no. 4, pp. 605–607, 2007. View at Google Scholar · View at Scopus
  22. S. A. Klotz, P. L. Dorn, J. H. Klotz et al., “Feeding behavior of triatomines from the southwestern United States: an update on potential risk for transmission of Chagas disease,” Acta Tropica, vol. 111, no. 2, pp. 114–118, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Cetron, “The world and its moving parts,” in Institute of Medicine Workshop on the Impact of Globalization on Infectious Disease Emergence and Control: Exploring the Consequences and Opportunities, Institute of Medicne Forum on Emerging Infections, Washington, DC, USA, 2002.
  24. C. Bern and S. P. Montgomery, “An estimate of the burden of chagas disease in the United States,” Clinical Infectious Diseases, vol. 49, no. 5, pp. e52–e54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. G. A. Schmunis and Z. E. Yadon, “Chagas disease: a Latin American health problem becoming a world health problem,” Acta Tropica, vol. 115, no. 1-2, pp. 14–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. US Census Bureau, United States Foreign-Born Population, 2000.
  27. D. A. Leiby, R. M. Herron, E. J. Read, B. A. Lenes, and R. J. Stumpf, “Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission,” Transfusion, vol. 42, no. 5, pp. 549–555, 2002. View at Google Scholar · View at Scopus
  28. Y. Wu, S. A. Glynn, G. B. Schreiber et al., “First-time blood donors: demographic trends,” Transfusion, vol. 41, no. 3, pp. 360–364, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. G. A. Schmunis, “Epidemiology of Chagas disease in non-endemic countries: the role of international migration,” Memorias do Instituto Oswaldo Cruz, vol. 102, no. 1, pp. 75–85, 2007. View at Google Scholar · View at Scopus
  30. American Associated of Blood Banks, “AAB Chagas' disease biovigilance network,” 2011, http://www.aabb.org/programs/biovigilance/Pages/chagas.aspx.
  31. R. J. Benjamin, S. L. Stramer, D. A. Leiby, R. Y. Dodd, M. Fearon, and E. Castro, “Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission,” Transfusion, vol. 52, no. 9, pp. 1913–1921, 2012. View at Google Scholar
  32. C. Bern, S. Kjos, M. J. Yabsley et al., “Trypanosoma cruzi and Chagas' disease in the United States,” Clinical Microbiology Reviews, vol. 24, no. 4, pp. 655–681, 2011. View at Google Scholar
  33. L. S. Steele, D. W. MacPherson, J. Kim, J. S. Keystone, and B. D. Gushulak, “The sero-prevalence of antibodies to Trypanosoma cruzi in Latin American refugees and immigrants to Canada,” Journal of Immigrant and Minority Health, vol. 9, no. 1, pp. 43–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. P. O. Pehrson, M. Wahlgren, and E. Bengtsson, “Asymptomatic congenital Chagas' disease in a 5-year-old child,” Scandinavian Journal of Infectious Diseases, vol. 13, no. 4, pp. 307–308, 1981. View at Google Scholar · View at Scopus
  35. P. Albajar-Vinas and J. Jannin, “The hidden Chagas disease burden in Europe,” Euro Surveillance, vol. 16, no. 38, 2011. View at Google Scholar
  36. K. Vasileva, “Statistics in focus. Citizens of European countries account for the majority of the foreign population in EU-27 in 2008,” Eurostat 94/2009, Luxembourg, Luxembourg, 2009. View at Google Scholar
  37. L. Basile, J. M. Jansa, Y. Carlier et al., “Chagas disease in European countries: the challenge of a surveillance system,” American Journal of Tropical Medicine and Hygiene, vol. 81, no. 6, pp. 927–933, 2009. View at Google Scholar
  38. J. Gascon, “Diagnosis and treatment of imported Chagas disease,” Medicina Clínica, vol. 125, no. 6, pp. 230–235, 2005. View at Google Scholar
  39. M. Piron, M. Vergés, J. Muñoz et al., “Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain),” Transfusion, vol. 48, no. 9, pp. 1862–1868, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Parada, E. Vila, and J. Villaba, “Determinacion de Trypanosoma cruzi: estudio preliminar de prevalencia en donantes de sangre,” Tech. Rep., Centro de Transfusion, Comunidad Valenciana, Resumen del Congreso SETS, Sa Sebastian, Spain, 2005. View at Google Scholar
  41. C. Barona-Vilar, M. J. Giménez-Martí, T. Fraile et al., “Prevalence of Trypanosoma cruzi infection in pregnant Latin American women and congenital transmission rate in a non-endemic area: the experience of the Valencian Health Programme (Spain),” Epidemiology & Infection, vol. 140, no. 10, pp. 1896–1903, 2012. View at Google Scholar
  42. M. D. Flores-Chavez, F. J. Merino, S. Garcia-Bujalance et al., “Surveillance of Chagas disease in pregnant women in Madrid, Spain, from 2008 to 2010,” Euro Surveillance, vol. 16, no. 38, 2011. View at Google Scholar
  43. M. Anselmi, A. Angheben, and M. Degani, “Imported Chagas disease in italy: preliminary screening results of selected immigrant populations,” Tropical Medicine & International Health, vol. 14, supplement 2, p. 74, 2009. View at Google Scholar
  44. A. Assal and C. Corbi, “Chagas disease and blood transfusion: an emerging issue in non-endemic countries,” Transfusion Clinique et Biologique, vol. 18, no. 2, pp. 286–291, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Frank, B. Hegenscheid, K. Janitschke, and T. Weinke, “Prevalence and epidemiological significance of Trypanosoma cruzi infection among Latin American immigrants in Berlin, Germany,” Infection, vol. 25, no. 6, pp. 355–358, 1997. View at Google Scholar · View at Scopus
  46. J. R. Verani, A. Seitz, R. H. Gilman et al., “Geographie variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection,” American Journal of Tropical Medicine and Hygiene, vol. 80, no. 3, pp. 410–415, 2009. View at Google Scholar · View at Scopus
  47. H. A. Lennox, D. A. Karcz, H. Tales, and M. El Masri, “Chagas disease: clinical overview and implications for nursing,” Medsurg Nursing, vol. 16, no. 4, pp. 229–236, 2007. View at Google Scholar · View at Scopus
  48. C. Bern, S. P. Montgomery, L. Katz, S. Caglioti, and S. L. Stramer, “Chagas disease and the US blood supply,” Current Opinion in Infectious Diseases, vol. 21, no. 5, pp. 476–482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. B. S. Schwartz, M. Paster, M. G. Ison, and P. V. Chin-Hong, “Organ donor screening practices for Trypanosoma cruzi infection among US organ procurement organizations,” American Journal of Transplantation, vol. 11, no. 4, pp. 848–851, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. G. A. Schmunis, “Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries,” Transfusion, vol. 31, no. 6, pp. 547–557, 1991. View at Google Scholar · View at Scopus
  51. D. Dzib, V. P. Hernández, B. C. Ake, R. A. López, and V. M. Monteón, “Leukoreduction by centrifugation does not eliminate Trypanosoma cruzi from infected blood units,” Vector-Borne and Zoonotic Diseases, vol. 9, no. 3, pp. 235–241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Moraes-Souza, J. O. Bordin, L. Bardossy, D. W. MacPherson, and M. A. Blajchman, “Prevention of transfusion-associated Chagas' disease: efficacy of white cell-reduction filters in removing Trypanosoma cruzi from infected blood,” Transfusion, vol. 35, no. 9, pp. 723–726, 1995. View at Google Scholar · View at Scopus
  53. D. A. Leiby, L. Nguyen, C. Procter, L. Townsend, and S. L. Stramer, “Impact of Trypanosoma cruzi phylogenetic lineage on transfusion transmission in the United States,” Vox Sanguinis, vol. 99, supplement 1, p. 64, 2011. View at Google Scholar
  54. B. Custer, M. Agopova, H. Biswas, M. Busch, P. Tomasulo, and H. Kamel, “Do pre-donation questions identify donors at higher risk for Trypanosoma cruzi infection?” Transfusion, vol. 49, supplement 1, p. 17A, 2009. View at Google Scholar
  55. Centers for Disease Control and Prevention (CDC), “Chagas disease after organ transplantation—United States, 2001,” Morbidity and Mortality Weekly Report, vol. 51, no. 10, pp. 210–212, 2002. View at Google Scholar
  56. P. Martin-Davila, J. Fortun, R. Lopez-Velez et al., “Transmission of tropical and geographically restricted infections during solid-organ transplantation,” Clinical Microbiology Reviews, vol. 21, no. 1, pp. 60–96, 2008. View at Google Scholar
  57. M. J. Pinazo, B. Miranda, C. Rodríguez-Villar et al., “Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas,” Transplantation Reviews, vol. 25, no. 3, pp. 91–101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. Centers for Disease Control and Prevention (CDC), “Chagas disease after organ transplantation—Los Angeles, California, 2006,” Morbidity and Mortality Weekly Report, vol. 55, no. 29, pp. 798–800, 2006. View at Google Scholar
  59. L. A. Benvenuti, A. Roggério, N. V. Sambiase, A. Fiorelli, and M. D. L. Higuchi, “Polymerase chain reaction in endomyocardial biopsies for monitoring reactivation of Chagas' disease in heart transplantation: a case report and review of the literature,” Cardiovascular Pathology, vol. 14, no. 5, pp. 265–268, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. R. B. Bestetti, P. M. Cury, T. A. D. Theodoropoulos, and D. Villafanha, “Trypanosoma cruzi myocardial infection reactivation presenting as complete atrioventricular block in a Chagas' heart transplant recipient,” Cardiovascular Pathology, vol. 13, no. 6, pp. 323–326, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. R. W. Evans, “Ethnocentrism is an unacceptable rationale for health care policy: a critique of transplant tourism position statements,” American Journal of Transplantation, vol. 8, no. 6, pp. 1089–1095, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. M. A. Shikanai-Yasuda and N. B. Carvalho, “Oral transmission of Chagas disease,” Clinical Infectious Diseases, vol. 54, no. 6, pp. 845–852, 2012. View at Google Scholar
  63. M. A. Shikanai-Yasuda, C. B. Marcondes, L. A. Guedes et al., “Possible oral transmission of acute Chagas' disease in Brazil,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 33, no. 5, pp. 351–357, 1991. View at Google Scholar · View at Scopus
  64. P. R. Benchimol Barbosa, “The oral transmission of Chagas' disease: an acute form of infection responsible for regional outbreaks,” International Journal of Cardiology, vol. 112, no. 1, pp. 132–133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. J. H. Maguire, R. Hoff, and A. C. Sleigh, “An outbreak of Chagas' disease in southwestern Bahia, Brazil,” American Journal of Tropical Medicine and Hygiene, vol. 35, no. 5, pp. 931–936, 1986. View at Google Scholar · View at Scopus
  66. A. A. Nóbrega, M. H. Garcia, E. Tatto et al., “Oral transmission of chagas disease by consumption of Açaí palm fruit, Brazil,” Emerging Infectious Diseases, vol. 15, no. 4, pp. 653–655, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. A. Y. Pinto, S. A. Valente, C. Valente Vda, A. G. Ferreira Junior, and J. R. Coura, “Acute phase of Chagas disease in the Brazilian Amazon region: study of 233 cases from Para, Amapa and Maranhao observed between 1988 and 2005,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 41, no. 6, pp. 602–614, 2008. View at Google Scholar
  68. L. M. Hernandez, A. N. Ramirez, Z. M. Cucunaba, and P. Zambrano, “Brote de Chagas agudo en Lebrija, Santander 2008,” Revista Del Observatorio de Salud Publica de Santander, vol. 1, no. 28, 2009. View at Google Scholar
  69. B. A. De Noya, Z. Díaz-Bello, C. Colmenares et al., “Large urban outbreak of orally acquired acute chagas disease at a school in Caracas, Venezuela,” Journal of Infectious Diseases, vol. 201, no. 9, pp. 1308–1315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Freilij and J. Altcheh, “Congenital Chagas' disease: diagnostic and clinical aspects,” Clinical Infectious Diseases, vol. 21, no. 3, pp. 551–555, 1995. View at Google Scholar · View at Scopus
  71. R. E. Gürtler, E. L. Segura, and J. E. Cohen, “Congenital transmission of Trypanosoma cruzi infection in Argentina,” Emerging Infectious Diseases, vol. 9, no. 1, pp. 29–32, 2003. View at Google Scholar · View at Scopus
  72. F. Torrico, C. Alonso-Vega, E. Suarez et al., “Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia,” American Journal of Tropical Medicine and Hygiene, vol. 70, no. 2, pp. 201–209, 2004. View at Google Scholar · View at Scopus
  73. S. Ciesielski, J. R. Seed, J. Estrada, and E. Wrenn, “The seroprevalence of cysticercosis, malaria, and Trypanosoma cruzi among North Carolina migrant farmworkers,” Public Health Reports, vol. 108, no. 6, pp. 736–741, 1993. View at Google Scholar · View at Scopus
  74. N. A. Salas, M. Cot, D. Schneider et al., “Risk factors and consequences of congenital Chagas disease in Yacuiba, south Bolivia,” Tropical Medicine and International Health, vol. 12, no. 12, pp. 1498–1505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. E. Hermann, C. Truyens, C. Alonso-Vega et al., “Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitemia and decreased production of interferon-γ in response to parasite antigens,” Journal of Infectious Diseases, vol. 189, no. 7, pp. 1274–1281, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Moncayo, “Chagas disease: epidemiology and prospects for interruption of transmission in the Americas,” World Health Statistics Quarterly, vol. 45, no. 2-3, pp. 276–279, 1992. View at Google Scholar · View at Scopus
  77. E. A. De Castilho and G. R. Da Silva, “Maternal Chagas' infection and prematurity,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 18, no. 4, pp. 258–260, 1976. View at Google Scholar · View at Scopus
  78. I. M. Hernandez-Matheson, R. F. Frankowski, and B. Held, “Foeto-maternal morbidity in the presence of antibodies to Trypanosoma cruzi,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 77, no. 3, pp. 405–411, 1983. View at Google Scholar · View at Scopus
  79. H. Schenone, C. M. Del Contreras, and J. M. Borgono, “Congenital Chagas' disease in Chile. Longitudinal study of reproductivity of chagasic and non-chagasic women and of some parasitological and clinical parameters from them and their corresponding children,” Boletin Chileno de Parasitologia, vol. 40, no. 1-2, pp. 24–29, 1985. View at Google Scholar · View at Scopus
  80. A. Pellegrino, “Migration from Latin America to Europe: trends and policy challenges,” IOM Migration Research Series 16, International Organization for Migration, Geneva, Switzerland, 2004. View at Google Scholar
  81. M. C. Di Pentima, L. Y. Hwang, C. M. Skeeter, and M. S. Edwards, “Prevalence of antibody to Trypanosoma cruzi in pregnant hispanic women in Houston,” Clinical Infectious Diseases, vol. 28, no. 6, pp. 1281–1285, 1999. View at Google Scholar · View at Scopus
  82. Z. E. Yadon and G. A. Schmunis, “Congenital chagas disease: estimating the potential risk in the United States,” American Journal of Tropical Medicine and Hygiene, vol. 81, no. 6, pp. 927–933, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. Y. Jackson, L. Gétaz, H. Wolff et al., “Prevalence, clinical staging and risk for blood-borne transmission of chagas disease among latin American migrants in Geneva, Switzerland,” PLoS Neglected Tropical Diseases, vol. 4, no. 2, article e592, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. D. A. Leiby, M. C. H. Fucci, and R. J. Stumpf, “Trypanosoma cruzi in a low- to moderate-risk blood donor population: seroprevalence and possible congenital transmission,” Transfusion, vol. 39, no. 3, pp. 310–315, 1999. View at Google Scholar · View at Scopus
  85. P. Buekens, O. Almendares, Y. Carlier et al., “Mother-to-child transmission of chagas' disease in North America: why don't we do more?” Maternal and Child Health Journal, vol. 12, no. 3, pp. 283–286, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. A. L. S. Sgambatti De Andrade, F. Zicker, R. M. De Oliveira et al., “Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection,” The Lancet, vol. 348, no. 9039, pp. 1407–1413, 1996. View at Publisher · View at Google Scholar · View at Scopus
  87. S. S. Estani, E. L. Segura, A. M. Ruiz, E. Velazquez, B. M. Porcel, and C. Yampotis, “Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease,” American Journal of Tropical Medicine and Hygiene, vol. 59, no. 4, pp. 526–529, 1998. View at Google Scholar · View at Scopus
  88. C. Bern, S. P. Montgomery, B. L. Herwaldt et al., “Evaluation and treatment of chagas disease in the United States: a systematic review,” Journal of the American Medical Association, vol. 298, no. 18, pp. 2171–2181, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. H. S. Margolis, P. J. Coleman, R. E. Brown, E. E. Mast, S. H. Sheingold, and J. A. Arevalo, “Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations,” Journal of the American Medical Association, vol. 274, no. 15, pp. 1201–1208, 1995. View at Google Scholar · View at Scopus
  90. R. Storino and J. Milei, Enfermedad de Chagas, Mosby-Doyma, Buenos Aires, Argentina, 1994.
  91. R. A. Guerri-Guttenberg, D. R. Grana, G. Ambrosio, and J. Milei, “Chagas cardiomyopathy: europe is not spared!,” European Heart Journal, vol. 29, no. 21, pp. 2587–2591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. L. V. Kirchhoff, J. R. Votava, D. E. Ochs, and D. R. Moser, “Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi,” Journal of Clinical Microbiology, vol. 34, no. 5, pp. 1171–1175, 1996. View at Google Scholar · View at Scopus
  93. L. V. Kirchhoff, “Current concepts: American trypanosomiasis (Chagas' disease)—a tropical disease now in the United States,” New England Journal of Medicine, vol. 329, no. 9, pp. 639–644, 1993. View at Publisher · View at Google Scholar · View at Scopus
  94. K. K. Stimpert and S. P. Montgomery, “Physician awareness of Chagas disease, USA,” Emerging Infectious Diseases, vol. 16, no. 5, pp. 871–872, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. Medecins Sans Frontieres, Shortage of Benznidazole Leaves Thousands of Chagas Patients without Treatment, Medecins Sans Frontieres, 2011.
  96. M. Doty and B. Ives, “Quality of health care for Hispanic populations. Findings from the Commonwealth Fund 2001 health care quality survey,” Tech. Rep. 526, New York, NY, USA, Commonwealth Fund, 2002. View at Google Scholar
  97. C. Di Girolamo, C. Bodini, and B. L. Marta, “Chagas disease at the crossroad of international migration and public health policies: why a national screening might not be enough,” Euro Surveillance, vol. 16, no. 37, 2011. View at Google Scholar
  98. R. Briceno Leon and J. Mendez Galvan, “The social determinants of Chagas disease and the transformations of Latin America,” Memórias do Instituto Oswaldo Cruz, vol. 102, supplement 1, pp. 109–112, 2007. View at Google Scholar
  99. R. Storino, “La cara oculta de la enfermeded de Chagas,” Revista de la Federacion Argentina de Cardiologia, vol. 29, no. 31, 2000. View at Google Scholar
  100. C. Di Girolamo, B. L. Marta, A. Ciannameo et al., “Chagas disease in a non endemic country: a study in the district of Bologna (Italy). Multidisciplinary analysis of the disease in the Latin American migrant population,” Annali di Igiene, vol. 22, no. 5, pp. 431–445, 2010. View at Google Scholar · View at Scopus
  101. Platform for International Cooperation on Undocumented Migrants (PICUM), “Helath care in nowhereland: improving services for undocumented migrants in the EU,” in Workpackage No. 6: The Voice of Undocumented Migrants. Undocumented Migrants' Health Needs and Strategies to Access Health Care in 17 EU countries, PICUM, Brussels, Belgium, June 2010.
  102. “Neglected parasitic infections in the United States,” http://www.cdc.gov/parasites/npi.html.
  103. “A new global effort to eliminate Chagas disease 2007,” http://www.who.int/mediacentre/news/releases/2007/pr36/en/index.html.